Deepa D. Nakmode
YOU?
Author Swipe
View article: Development of an in-situ forming implant system for levodopa and carbidopa for the treatment of parkinson’s disease
Development of an in-situ forming implant system for levodopa and carbidopa for the treatment of parkinson’s disease Open
Long-acting injectables have gained attraction as a system for treating chronic conditions due to their increased efficacy, safety, and patient compliance. Currently, patients with Parkinsons need to administer oral medications multiple ti…
View article: Unveiling the Future: Opportunities in Long-Acting Injectable Drug Development for Veterinary Care
Unveiling the Future: Opportunities in Long-Acting Injectable Drug Development for Veterinary Care Open
Long-acting injectable (LAI) formulations have revolutionized veterinary pharmaceuticals by improving patient compliance, minimizing dosage frequency, and improving therapeutic efficacy. These formulations utilize advanced drug delivery te…
View article: Analytical method for simultaneous quantification of levodopa and carbidopa in the injectable oleogel formulation by HPLC
Analytical method for simultaneous quantification of levodopa and carbidopa in the injectable oleogel formulation by HPLC Open
View article: Correction: Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologies
Correction: Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologies Open
View article: Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologies
Long-acting parenteral formulations of hydrophilic drugs, proteins, and peptide therapeutics: mechanisms, challenges, and therapeutic benefits with a focus on technologies Open
Despite being the most widely prescribed formulation, oral formulations possess several limitations such as low adherence, low bioavailability, high toxicity (in the case of anticancer drugs), and multiple-time administration requirements.…
View article: The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems
The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems Open
Parkinson’s disease (PD) has significantly affected a large proportion of the elderly population worldwide. According to the World Health Organization, approximately 8.5 million people worldwide are living with PD. In the United States, an…